nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—GSTP1—Carboplatin—brain cancer	0.237	0.348	CbGbCtD
Clomipramine—GSTP1—Etoposide—brain cancer	0.199	0.292	CbGbCtD
Clomipramine—CYP2D6—Lomustine—brain cancer	0.0509	0.0745	CbGbCtD
Clomipramine—CYP1A2—Carmustine—brain cancer	0.0503	0.0737	CbGbCtD
Clomipramine—CYP2D6—Hydroxyurea—brain cancer	0.0385	0.0565	CbGbCtD
Clomipramine—CYP3A4—Temozolomide—brain cancer	0.038	0.0557	CbGbCtD
Clomipramine—CYP3A4—Lomustine—brain cancer	0.0323	0.0474	CbGbCtD
Clomipramine—CYP1A2—Etoposide—brain cancer	0.0149	0.0219	CbGbCtD
Clomipramine—ABCB1—Etoposide—brain cancer	0.013	0.0191	CbGbCtD
Clomipramine—HTR2C—choroid plexus—brain cancer	0.0113	0.122	CbGeAlD
Clomipramine—CYP3A4—Etoposide—brain cancer	0.00782	0.0114	CbGbCtD
Clomipramine—HTR2A—choroid plexus—brain cancer	0.00568	0.0614	CbGeAlD
Clomipramine—HTR6—ganglion—brain cancer	0.00357	0.0386	CbGeAlD
Clomipramine—HTR2C—telencephalic ventricle—brain cancer	0.00331	0.0359	CbGeAlD
Clomipramine—HTR2A—trigeminal nerve—brain cancer	0.00287	0.0311	CbGeAlD
Clomipramine—HTR2A—cerebellar cortex—brain cancer	0.00286	0.0309	CbGeAlD
Clomipramine—HTR2A—vein—brain cancer	0.00259	0.0281	CbGeAlD
Clomipramine—HTR2C—ganglion—brain cancer	0.00206	0.0223	CbGeAlD
Clomipramine—HTR2A—cranial nerve—brain cancer	0.00204	0.0221	CbGeAlD
Clomipramine—HTR2A—pons—brain cancer	0.00202	0.0219	CbGeAlD
Clomipramine—SLC6A4—ganglion—brain cancer	0.00196	0.0212	CbGeAlD
Clomipramine—Trifluoperazine—S100A4—brain cancer	0.00188	0.4	CrCbGaD
Clomipramine—SLC6A2—ganglion—brain cancer	0.00172	0.0186	CbGeAlD
Clomipramine—HTR2A—telencephalic ventricle—brain cancer	0.00166	0.018	CbGeAlD
Clomipramine—SLC6A4—hindbrain—brain cancer	0.00148	0.0161	CbGeAlD
Clomipramine—HTR2A—pineal body—brain cancer	0.00144	0.0156	CbGeAlD
Clomipramine—HTR6—telencephalon—brain cancer	0.00138	0.0149	CbGeAlD
Clomipramine—HTR2A—ganglion—brain cancer	0.00103	0.0112	CbGeAlD
Clomipramine—GSTP1—telencephalon—brain cancer	0.000907	0.00981	CbGeAlD
Clomipramine—HTR2C—brainstem—brain cancer	0.000897	0.0097	CbGeAlD
Clomipramine—HTR2A—endothelium—brain cancer	0.000892	0.00966	CbGeAlD
Clomipramine—HTR6—head—brain cancer	0.000858	0.00928	CbGeAlD
Clomipramine—SLC6A4—brainstem—brain cancer	0.00085	0.0092	CbGeAlD
Clomipramine—HTR2A—blood vessel—brain cancer	0.000823	0.00891	CbGeAlD
Clomipramine—HTR2C—telencephalon—brain cancer	0.000796	0.00861	CbGeAlD
Clomipramine—HRH2—endocrine gland—brain cancer	0.000794	0.00859	CbGeAlD
Clomipramine—HTR2A—hindbrain—brain cancer	0.000785	0.00849	CbGeAlD
Clomipramine—HRH2—head—brain cancer	0.000784	0.00849	CbGeAlD
Clomipramine—HTR6—central nervous system—brain cancer	0.000783	0.00847	CbGeAlD
Clomipramine—GSTP1—gonad—brain cancer	0.000757	0.00819	CbGeAlD
Clomipramine—SLC6A4—telencephalon—brain cancer	0.000754	0.00816	CbGeAlD
Clomipramine—SLC6A2—brainstem—brain cancer	0.000748	0.0081	CbGeAlD
Clomipramine—HTR2B—telencephalon—brain cancer	0.000748	0.00809	CbGeAlD
Clomipramine—GSTP1—pituitary gland—brain cancer	0.000738	0.00799	CbGeAlD
Clomipramine—HRH2—central nervous system—brain cancer	0.000716	0.00775	CbGeAlD
Clomipramine—CYP2D6—hindbrain—brain cancer	0.000715	0.00774	CbGeAlD
Clomipramine—GSTP1—medulla oblongata—brain cancer	0.000712	0.00771	CbGeAlD
Clomipramine—SLC6A2—telencephalon—brain cancer	0.000664	0.00719	CbGeAlD
Clomipramine—GSTP1—midbrain—brain cancer	0.000651	0.00705	CbGeAlD
Clomipramine—GSTP1—spinal cord—brain cancer	0.000635	0.00687	CbGeAlD
Clomipramine—HTR2C—medulla oblongata—brain cancer	0.000625	0.00677	CbGeAlD
Clomipramine—HTR6—brain—brain cancer	0.000621	0.00673	CbGeAlD
Clomipramine—GSTP1—endocrine gland—brain cancer	0.000572	0.00619	CbGeAlD
Clomipramine—HTR2C—midbrain—brain cancer	0.000572	0.00618	CbGeAlD
Clomipramine—HRH2—brain—brain cancer	0.000568	0.00615	CbGeAlD
Clomipramine—GSTP1—head—brain cancer	0.000565	0.00611	CbGeAlD
Clomipramine—HTR2C—spinal cord—brain cancer	0.000558	0.00603	CbGeAlD
Clomipramine—SLC6A2—gonad—brain cancer	0.000554	0.006	CbGeAlD
Clomipramine—SLC6A4—midbrain—brain cancer	0.000542	0.00586	CbGeAlD
Clomipramine—ABCB1—blood vessel—brain cancer	0.000539	0.00584	CbGeAlD
Clomipramine—SLC6A4—spinal cord—brain cancer	0.000529	0.00572	CbGeAlD
Clomipramine—SLC6A2—medulla oblongata—brain cancer	0.000522	0.00565	CbGeAlD
Clomipramine—GSTP1—central nervous system—brain cancer	0.000515	0.00558	CbGeAlD
Clomipramine—GSTP1—cerebellum—brain cancer	0.000504	0.00545	CbGeAlD
Clomipramine—HTR2C—head—brain cancer	0.000496	0.00536	CbGeAlD
Clomipramine—Carbinoxamine—CYP2C9—brain cancer	0.000479	0.102	CrCbGaD
Clomipramine—SLC6A4—endocrine gland—brain cancer	0.000476	0.00515	CbGeAlD
Clomipramine—SLC6A4—head—brain cancer	0.00047	0.00508	CbGeAlD
Clomipramine—ADRA2A—telencephalon—brain cancer	0.00047	0.00508	CbGeAlD
Clomipramine—HTR2B—head—brain cancer	0.000466	0.00504	CbGeAlD
Clomipramine—HTR2C—central nervous system—brain cancer	0.000452	0.0049	CbGeAlD
Clomipramine—HTR2A—brainstem—brain cancer	0.00045	0.00487	CbGeAlD
Clomipramine—SLC6A4—central nervous system—brain cancer	0.000429	0.00464	CbGeAlD
Clomipramine—HTR2B—central nervous system—brain cancer	0.000425	0.0046	CbGeAlD
Clomipramine—SLC6A2—endocrine gland—brain cancer	0.000419	0.00453	CbGeAlD
Clomipramine—SLC6A2—head—brain cancer	0.000414	0.00448	CbGeAlD
Clomipramine—CYP2D6—brainstem—brain cancer	0.00041	0.00443	CbGeAlD
Clomipramine—GSTP1—brain—brain cancer	0.000409	0.00443	CbGeAlD
Clomipramine—HTR2A—telencephalon—brain cancer	0.000399	0.00432	CbGeAlD
Clomipramine—CYP2C19—endocrine gland—brain cancer	0.000394	0.00427	CbGeAlD
Clomipramine—ADRA2A—gonad—brain cancer	0.000392	0.00424	CbGeAlD
Clomipramine—ADRA2A—pituitary gland—brain cancer	0.000382	0.00414	CbGeAlD
Clomipramine—SLC6A2—central nervous system—brain cancer	0.000378	0.00409	CbGeAlD
Clomipramine—ADRA2A—medulla oblongata—brain cancer	0.000369	0.00399	CbGeAlD
Clomipramine—CYP2D6—telencephalon—brain cancer	0.000364	0.00394	CbGeAlD
Clomipramine—HTR2C—brain—brain cancer	0.000359	0.00389	CbGeAlD
Clomipramine—ALB—brain—brain cancer	0.00035	0.00379	CbGeAlD
Clomipramine—SLC6A4—brain—brain cancer	0.00034	0.00368	CbGeAlD
Clomipramine—HTR2B—brain—brain cancer	0.000337	0.00365	CbGeAlD
Clomipramine—ADRA2A—midbrain—brain cancer	0.000337	0.00365	CbGeAlD
Clomipramine—HTR2A—gonad—brain cancer	0.000333	0.00361	CbGeAlD
Clomipramine—ADRA2A—spinal cord—brain cancer	0.000329	0.00356	CbGeAlD
Clomipramine—HTR2A—pituitary gland—brain cancer	0.000325	0.00352	CbGeAlD
Clomipramine—CYP1A2—endocrine gland—brain cancer	0.000322	0.00349	CbGeAlD
Clomipramine—HTR2A—medulla oblongata—brain cancer	0.000314	0.00339	CbGeAlD
Clomipramine—SLC6A2—brain—brain cancer	0.0003	0.00324	CbGeAlD
Clomipramine—Nortriptyline—CYP2C9—brain cancer	0.000299	0.0636	CrCbGaD
Clomipramine—Nausea—Lomustine—brain cancer	0.000297	0.00175	CcSEcCtD
Clomipramine—Hypotension—Procarbazine—brain cancer	0.000297	0.00175	CcSEcCtD
Clomipramine—ADRA2A—endocrine gland—brain cancer	0.000296	0.0032	CbGeAlD
Clomipramine—Neuropathy peripheral—Temozolomide—brain cancer	0.000295	0.00174	CcSEcCtD
Clomipramine—Urinary tract infection—Temozolomide—brain cancer	0.000293	0.00173	CcSEcCtD
Clomipramine—ADRA2A—head—brain cancer	0.000292	0.00316	CbGeAlD
Clomipramine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00029	0.00171	CcSEcCtD
Clomipramine—Thioridazine—CYP2C9—brain cancer	0.000288	0.0613	CrCbGaD
Clomipramine—Insomnia—Procarbazine—brain cancer	0.000287	0.00169	CcSEcCtD
Clomipramine—HTR2A—midbrain—brain cancer	0.000287	0.0031	CbGeAlD
Clomipramine—Paraesthesia—Procarbazine—brain cancer	0.000285	0.00168	CcSEcCtD
Clomipramine—Hepatobiliary disease—Temozolomide—brain cancer	0.000285	0.00168	CcSEcCtD
Clomipramine—Sinusitis—Temozolomide—brain cancer	0.000283	0.00167	CcSEcCtD
Clomipramine—Somnolence—Procarbazine—brain cancer	0.000283	0.00166	CcSEcCtD
Clomipramine—Trimipramine—CYP2C9—brain cancer	0.000281	0.0599	CrCbGaD
Clomipramine—HTR2A—spinal cord—brain cancer	0.00028	0.00303	CbGeAlD
Clomipramine—Ill-defined disorder—Hydroxyurea—brain cancer	0.00028	0.00165	CcSEcCtD
Clomipramine—Anaemia—Hydroxyurea—brain cancer	0.000279	0.00164	CcSEcCtD
Clomipramine—Hypoaesthesia—Carmustine—brain cancer	0.000279	0.00164	CcSEcCtD
Clomipramine—Hallucination—Carmustine—brain cancer	0.000279	0.00164	CcSEcCtD
Clomipramine—Decreased appetite—Procarbazine—brain cancer	0.000276	0.00163	CcSEcCtD
Clomipramine—Connective tissue disorder—Carmustine—brain cancer	0.000275	0.00162	CcSEcCtD
Clomipramine—Fatigue—Procarbazine—brain cancer	0.000274	0.00161	CcSEcCtD
Clomipramine—Malaise—Hydroxyurea—brain cancer	0.000272	0.0016	CcSEcCtD
Clomipramine—Pain—Procarbazine—brain cancer	0.000272	0.0016	CcSEcCtD
Clomipramine—Constipation—Procarbazine—brain cancer	0.000272	0.0016	CcSEcCtD
Clomipramine—Promethazine—CYP2C9—brain cancer	0.000271	0.0576	CrCbGaD
Clomipramine—Hepatitis—Temozolomide—brain cancer	0.00027	0.00159	CcSEcCtD
Clomipramine—Dysphagia—Etoposide—brain cancer	0.00027	0.00159	CcSEcCtD
Clomipramine—Leukopenia—Hydroxyurea—brain cancer	0.00027	0.00159	CcSEcCtD
Clomipramine—Visual impairment—Carmustine—brain cancer	0.00027	0.00159	CcSEcCtD
Clomipramine—Hallucination—Temozolomide—brain cancer	0.000269	0.00159	CcSEcCtD
Clomipramine—Hypoaesthesia—Temozolomide—brain cancer	0.000269	0.00159	CcSEcCtD
Clomipramine—Pharyngitis—Temozolomide—brain cancer	0.000268	0.00158	CcSEcCtD
Clomipramine—Doxepin—CYP2C9—brain cancer	0.000268	0.057	CrCbGaD
Clomipramine—Urinary tract disorder—Temozolomide—brain cancer	0.000267	0.00157	CcSEcCtD
Clomipramine—ADRA2A—central nervous system—brain cancer	0.000267	0.00289	CbGeAlD
Clomipramine—Bronchospasm—Etoposide—brain cancer	0.000266	0.00157	CcSEcCtD
Clomipramine—Connective tissue disorder—Temozolomide—brain cancer	0.000266	0.00157	CcSEcCtD
Clomipramine—Urethral disorder—Temozolomide—brain cancer	0.000265	0.00156	CcSEcCtD
Clomipramine—Perphenazine—CYP2C9—brain cancer	0.000264	0.0562	CrCbGaD
Clomipramine—Sweating increased—Etoposide—brain cancer	0.000263	0.00155	CcSEcCtD
Clomipramine—Feeling abnormal—Procarbazine—brain cancer	0.000262	0.00154	CcSEcCtD
Clomipramine—ABCB1—telencephalon—brain cancer	0.000262	0.00283	CbGeAlD
Clomipramine—Eye disorder—Carmustine—brain cancer	0.000262	0.00154	CcSEcCtD
Clomipramine—Convulsion—Hydroxyurea—brain cancer	0.000261	0.00154	CcSEcCtD
Clomipramine—ADRA2A—cerebellum—brain cancer	0.000261	0.00282	CbGeAlD
Clomipramine—Visual impairment—Temozolomide—brain cancer	0.000261	0.00154	CcSEcCtD
Clomipramine—Gastrointestinal pain—Procarbazine—brain cancer	0.00026	0.00153	CcSEcCtD
Clomipramine—Flushing—Carmustine—brain cancer	0.00026	0.00153	CcSEcCtD
Clomipramine—Pancytopenia—Etoposide—brain cancer	0.000257	0.00151	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000255	0.0015	CcSEcCtD
Clomipramine—Discomfort—Hydroxyurea—brain cancer	0.000254	0.00149	CcSEcCtD
Clomipramine—Eye disorder—Temozolomide—brain cancer	0.000253	0.00149	CcSEcCtD
Clomipramine—Urticaria—Procarbazine—brain cancer	0.000253	0.00149	CcSEcCtD
Clomipramine—Tinnitus—Temozolomide—brain cancer	0.000252	0.00149	CcSEcCtD
Clomipramine—HTR2A—endocrine gland—brain cancer	0.000252	0.00272	CbGeAlD
Clomipramine—Body temperature increased—Procarbazine—brain cancer	0.000251	0.00148	CcSEcCtD
Clomipramine—Abdominal pain—Procarbazine—brain cancer	0.000251	0.00148	CcSEcCtD
Clomipramine—Flushing—Temozolomide—brain cancer	0.000251	0.00148	CcSEcCtD
Clomipramine—Cardiac disorder—Temozolomide—brain cancer	0.000251	0.00148	CcSEcCtD
Clomipramine—Arrhythmia—Carmustine—brain cancer	0.00025	0.00147	CcSEcCtD
Clomipramine—HTR2A—head—brain cancer	0.000249	0.00269	CbGeAlD
Clomipramine—Alopecia—Carmustine—brain cancer	0.000247	0.00146	CcSEcCtD
Clomipramine—Oedema—Hydroxyurea—brain cancer	0.000246	0.00145	CcSEcCtD
Clomipramine—Angiopathy—Temozolomide—brain cancer	0.000245	0.00145	CcSEcCtD
Clomipramine—Mental disorder—Carmustine—brain cancer	0.000245	0.00144	CcSEcCtD
Clomipramine—Immune system disorder—Temozolomide—brain cancer	0.000244	0.00144	CcSEcCtD
Clomipramine—Mediastinal disorder—Temozolomide—brain cancer	0.000244	0.00144	CcSEcCtD
Clomipramine—Malnutrition—Carmustine—brain cancer	0.000244	0.00144	CcSEcCtD
Clomipramine—Chills—Temozolomide—brain cancer	0.000243	0.00143	CcSEcCtD
Clomipramine—Pneumonia—Etoposide—brain cancer	0.000243	0.00143	CcSEcCtD
Clomipramine—Nervous system disorder—Hydroxyurea—brain cancer	0.000241	0.00142	CcSEcCtD
Clomipramine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000241	0.00142	CcSEcCtD
Clomipramine—Alopecia—Temozolomide—brain cancer	0.000239	0.00141	CcSEcCtD
Clomipramine—Skin disorder—Hydroxyurea—brain cancer	0.000239	0.00141	CcSEcCtD
Clomipramine—Promazine—CYP2C9—brain cancer	0.000238	0.0507	CrCbGaD
Clomipramine—Acute coronary syndrome—Etoposide—brain cancer	0.000238	0.0014	CcSEcCtD
Clomipramine—Mental disorder—Temozolomide—brain cancer	0.000237	0.0014	CcSEcCtD
Clomipramine—Myocardial infarction—Etoposide—brain cancer	0.000236	0.00139	CcSEcCtD
Clomipramine—Neuropathy peripheral—Etoposide—brain cancer	0.000236	0.00139	CcSEcCtD
Clomipramine—Back pain—Carmustine—brain cancer	0.000236	0.00139	CcSEcCtD
Clomipramine—Malnutrition—Temozolomide—brain cancer	0.000235	0.00139	CcSEcCtD
Clomipramine—Jaundice—Etoposide—brain cancer	0.000235	0.00138	CcSEcCtD
Clomipramine—Anorexia—Hydroxyurea—brain cancer	0.000234	0.00138	CcSEcCtD
Clomipramine—Hypersensitivity—Procarbazine—brain cancer	0.000234	0.00138	CcSEcCtD
Clomipramine—CYP3A4—endocrine gland—brain cancer	0.000233	0.00252	CbGeAlD
Clomipramine—Dysgeusia—Temozolomide—brain cancer	0.000231	0.00136	CcSEcCtD
Clomipramine—Vision blurred—Carmustine—brain cancer	0.00023	0.00135	CcSEcCtD
Clomipramine—CYP2D6—endocrine gland—brain cancer	0.000229	0.00248	CbGeAlD
Clomipramine—Tremor—Carmustine—brain cancer	0.000228	0.00134	CcSEcCtD
Clomipramine—Asthenia—Procarbazine—brain cancer	0.000228	0.00134	CcSEcCtD
Clomipramine—Hepatobiliary disease—Etoposide—brain cancer	0.000228	0.00134	CcSEcCtD
Clomipramine—Back pain—Temozolomide—brain cancer	0.000228	0.00134	CcSEcCtD
Clomipramine—HTR2A—central nervous system—brain cancer	0.000227	0.00246	CbGeAlD
Clomipramine—CYP2D6—head—brain cancer	0.000226	0.00245	CbGeAlD
Clomipramine—Diazepam—CYP2C9—brain cancer	0.000226	0.048	CrCbGaD
Clomipramine—Anaemia—Carmustine—brain cancer	0.000225	0.00133	CcSEcCtD
Clomipramine—Agranulocytosis—Etoposide—brain cancer	0.000225	0.00133	CcSEcCtD
Clomipramine—Pruritus—Procarbazine—brain cancer	0.000225	0.00132	CcSEcCtD
Clomipramine—Agitation—Carmustine—brain cancer	0.000224	0.00132	CcSEcCtD
Clomipramine—Vision blurred—Temozolomide—brain cancer	0.000222	0.00131	CcSEcCtD
Clomipramine—HTR2A—cerebellum—brain cancer	0.000222	0.0024	CbGeAlD
Clomipramine—Tremor—Temozolomide—brain cancer	0.000221	0.0013	CcSEcCtD
Clomipramine—Dyspnoea—Hydroxyurea—brain cancer	0.000219	0.00129	CcSEcCtD
Clomipramine—Somnolence—Hydroxyurea—brain cancer	0.000219	0.00129	CcSEcCtD
Clomipramine—Ill-defined disorder—Temozolomide—brain cancer	0.000218	0.00129	CcSEcCtD
Clomipramine—ABCB1—gonad—brain cancer	0.000218	0.00236	CbGeAlD
Clomipramine—Leukopenia—Carmustine—brain cancer	0.000218	0.00128	CcSEcCtD
Clomipramine—Anaemia—Temozolomide—brain cancer	0.000218	0.00128	CcSEcCtD
Clomipramine—Diarrhoea—Procarbazine—brain cancer	0.000217	0.00128	CcSEcCtD
Clomipramine—Dyspepsia—Hydroxyurea—brain cancer	0.000217	0.00128	CcSEcCtD
Clomipramine—Agitation—Temozolomide—brain cancer	0.000216	0.00127	CcSEcCtD
Clomipramine—Hypoaesthesia—Etoposide—brain cancer	0.000215	0.00127	CcSEcCtD
Clomipramine—Decreased appetite—Hydroxyurea—brain cancer	0.000214	0.00126	CcSEcCtD
Clomipramine—Urinary tract disorder—Etoposide—brain cancer	0.000214	0.00126	CcSEcCtD
Clomipramine—ABCB1—pituitary gland—brain cancer	0.000213	0.00231	CbGeAlD
Clomipramine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000212	0.00125	CcSEcCtD
Clomipramine—Malaise—Temozolomide—brain cancer	0.000212	0.00125	CcSEcCtD
Clomipramine—Urethral disorder—Etoposide—brain cancer	0.000212	0.00125	CcSEcCtD
Clomipramine—Fatigue—Hydroxyurea—brain cancer	0.000212	0.00125	CcSEcCtD
Clomipramine—ADRA2A—brain—brain cancer	0.000212	0.00229	CbGeAlD
Clomipramine—Vertigo—Temozolomide—brain cancer	0.000212	0.00125	CcSEcCtD
Clomipramine—Convulsion—Carmustine—brain cancer	0.000211	0.00124	CcSEcCtD
Clomipramine—Leukopenia—Temozolomide—brain cancer	0.000211	0.00124	CcSEcCtD
Clomipramine—Hypertension—Carmustine—brain cancer	0.00021	0.00124	CcSEcCtD
Clomipramine—Pain—Hydroxyurea—brain cancer	0.00021	0.00124	CcSEcCtD
Clomipramine—Constipation—Hydroxyurea—brain cancer	0.00021	0.00124	CcSEcCtD
Clomipramine—Dizziness—Procarbazine—brain cancer	0.00021	0.00124	CcSEcCtD
Clomipramine—CYP3A4—central nervous system—brain cancer	0.00021	0.00227	CbGeAlD
Clomipramine—Palpitations—Temozolomide—brain cancer	0.000208	0.00123	CcSEcCtD
Clomipramine—Chest pain—Carmustine—brain cancer	0.000207	0.00122	CcSEcCtD
Clomipramine—Myalgia—Carmustine—brain cancer	0.000207	0.00122	CcSEcCtD
Clomipramine—Amitriptyline—CYP2C9—brain cancer	0.000207	0.0441	CrCbGaD
Clomipramine—Anxiety—Carmustine—brain cancer	0.000207	0.00122	CcSEcCtD
Clomipramine—CYP2D6—central nervous system—brain cancer	0.000207	0.00224	CbGeAlD
Clomipramine—ABCB1—medulla oblongata—brain cancer	0.000206	0.00222	CbGeAlD
Clomipramine—Cough—Temozolomide—brain cancer	0.000205	0.00121	CcSEcCtD
Clomipramine—Convulsion—Temozolomide—brain cancer	0.000204	0.0012	CcSEcCtD
Clomipramine—Hypertension—Temozolomide—brain cancer	0.000203	0.0012	CcSEcCtD
Clomipramine—Feeling abnormal—Hydroxyurea—brain cancer	0.000203	0.00119	CcSEcCtD
Clomipramine—Eye disorder—Etoposide—brain cancer	0.000202	0.00119	CcSEcCtD
Clomipramine—Vomiting—Procarbazine—brain cancer	0.000202	0.00119	CcSEcCtD
Clomipramine—CYP2D6—cerebellum—brain cancer	0.000202	0.00219	CbGeAlD
Clomipramine—Flushing—Etoposide—brain cancer	0.000201	0.00118	CcSEcCtD
Clomipramine—Cardiac disorder—Etoposide—brain cancer	0.000201	0.00118	CcSEcCtD
Clomipramine—Confusional state—Carmustine—brain cancer	0.000201	0.00118	CcSEcCtD
Clomipramine—Myalgia—Temozolomide—brain cancer	0.0002	0.00118	CcSEcCtD
Clomipramine—Arthralgia—Temozolomide—brain cancer	0.0002	0.00118	CcSEcCtD
Clomipramine—Rash—Procarbazine—brain cancer	0.0002	0.00118	CcSEcCtD
Clomipramine—Dermatitis—Procarbazine—brain cancer	0.0002	0.00118	CcSEcCtD
Clomipramine—Anxiety—Temozolomide—brain cancer	0.0002	0.00118	CcSEcCtD
Clomipramine—Headache—Procarbazine—brain cancer	0.000199	0.00117	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000199	0.00117	CcSEcCtD
Clomipramine—Oedema—Carmustine—brain cancer	0.000199	0.00117	CcSEcCtD
Clomipramine—Discomfort—Temozolomide—brain cancer	0.000198	0.00117	CcSEcCtD
Clomipramine—Angiopathy—Etoposide—brain cancer	0.000196	0.00116	CcSEcCtD
Clomipramine—Dry mouth—Temozolomide—brain cancer	0.000196	0.00115	CcSEcCtD
Clomipramine—Immune system disorder—Etoposide—brain cancer	0.000196	0.00115	CcSEcCtD
Clomipramine—Mediastinal disorder—Etoposide—brain cancer	0.000195	0.00115	CcSEcCtD
Clomipramine—Thrombocytopenia—Carmustine—brain cancer	0.000195	0.00115	CcSEcCtD
Clomipramine—Body temperature increased—Hydroxyurea—brain cancer	0.000194	0.00115	CcSEcCtD
Clomipramine—Chills—Etoposide—brain cancer	0.000194	0.00114	CcSEcCtD
Clomipramine—Tachycardia—Carmustine—brain cancer	0.000194	0.00114	CcSEcCtD
Clomipramine—Confusional state—Temozolomide—brain cancer	0.000194	0.00114	CcSEcCtD
Clomipramine—Oedema—Temozolomide—brain cancer	0.000192	0.00113	CcSEcCtD
Clomipramine—Anaphylactic shock—Temozolomide—brain cancer	0.000192	0.00113	CcSEcCtD
Clomipramine—Alopecia—Etoposide—brain cancer	0.000191	0.00113	CcSEcCtD
Clomipramine—Anorexia—Carmustine—brain cancer	0.00019	0.00112	CcSEcCtD
Clomipramine—Nausea—Procarbazine—brain cancer	0.000189	0.00111	CcSEcCtD
Clomipramine—Nervous system disorder—Temozolomide—brain cancer	0.000188	0.00111	CcSEcCtD
Clomipramine—Thrombocytopenia—Temozolomide—brain cancer	0.000188	0.00111	CcSEcCtD
Clomipramine—ABCB1—midbrain—brain cancer	0.000188	0.00203	CbGeAlD
Clomipramine—Skin disorder—Temozolomide—brain cancer	0.000187	0.0011	CcSEcCtD
Clomipramine—Hypotension—Carmustine—brain cancer	0.000186	0.00109	CcSEcCtD
Clomipramine—Hyperhidrosis—Temozolomide—brain cancer	0.000186	0.00109	CcSEcCtD
Clomipramine—Dysgeusia—Etoposide—brain cancer	0.000185	0.00109	CcSEcCtD
Clomipramine—ABCB1—spinal cord—brain cancer	0.000183	0.00198	CbGeAlD
Clomipramine—Anorexia—Temozolomide—brain cancer	0.000183	0.00108	CcSEcCtD
Clomipramine—Back pain—Etoposide—brain cancer	0.000182	0.00107	CcSEcCtD
Clomipramine—Hypersensitivity—Hydroxyurea—brain cancer	0.000181	0.00107	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000181	0.00107	CcSEcCtD
Clomipramine—Muscle spasms—Etoposide—brain cancer	0.000181	0.00107	CcSEcCtD
Clomipramine—HTR2A—brain—brain cancer	0.00018	0.00195	CbGeAlD
Clomipramine—Insomnia—Carmustine—brain cancer	0.00018	0.00106	CcSEcCtD
Clomipramine—Paraesthesia—Carmustine—brain cancer	0.000179	0.00105	CcSEcCtD
Clomipramine—Dyspnoea—Carmustine—brain cancer	0.000177	0.00104	CcSEcCtD
Clomipramine—Somnolence—Carmustine—brain cancer	0.000177	0.00104	CcSEcCtD
Clomipramine—Asthenia—Hydroxyurea—brain cancer	0.000176	0.00104	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000175	0.00103	CcSEcCtD
Clomipramine—Ill-defined disorder—Etoposide—brain cancer	0.000175	0.00103	CcSEcCtD
Clomipramine—Anaemia—Etoposide—brain cancer	0.000174	0.00103	CcSEcCtD
Clomipramine—Insomnia—Temozolomide—brain cancer	0.000174	0.00102	CcSEcCtD
Clomipramine—Decreased appetite—Carmustine—brain cancer	0.000173	0.00102	CcSEcCtD
Clomipramine—Paraesthesia—Temozolomide—brain cancer	0.000173	0.00102	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Carmustine—brain cancer	0.000172	0.00101	CcSEcCtD
Clomipramine—Dyspnoea—Temozolomide—brain cancer	0.000171	0.00101	CcSEcCtD
Clomipramine—Somnolence—Temozolomide—brain cancer	0.000171	0.00101	CcSEcCtD
Clomipramine—Pain—Carmustine—brain cancer	0.00017	0.001	CcSEcCtD
Clomipramine—Constipation—Carmustine—brain cancer	0.00017	0.001	CcSEcCtD
Clomipramine—Malaise—Etoposide—brain cancer	0.00017	0.001	CcSEcCtD
Clomipramine—Vertigo—Etoposide—brain cancer	0.000169	0.000997	CcSEcCtD
Clomipramine—Dyspepsia—Temozolomide—brain cancer	0.000169	0.000996	CcSEcCtD
Clomipramine—Leukopenia—Etoposide—brain cancer	0.000169	0.000993	CcSEcCtD
Clomipramine—Diarrhoea—Hydroxyurea—brain cancer	0.000168	0.000991	CcSEcCtD
Clomipramine—Decreased appetite—Temozolomide—brain cancer	0.000167	0.000984	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000166	0.000977	CcSEcCtD
Clomipramine—Fatigue—Temozolomide—brain cancer	0.000166	0.000976	CcSEcCtD
Clomipramine—Loss of consciousness—Etoposide—brain cancer	0.000166	0.000975	CcSEcCtD
Clomipramine—ABCB1—endocrine gland—brain cancer	0.000165	0.00179	CbGeAlD
Clomipramine—Cough—Etoposide—brain cancer	0.000164	0.000969	CcSEcCtD
Clomipramine—Constipation—Temozolomide—brain cancer	0.000164	0.000968	CcSEcCtD
Clomipramine—Pain—Temozolomide—brain cancer	0.000164	0.000968	CcSEcCtD
Clomipramine—CYP2D6—brain—brain cancer	0.000164	0.00178	CbGeAlD
Clomipramine—Feeling abnormal—Carmustine—brain cancer	0.000164	0.000965	CcSEcCtD
Clomipramine—Convulsion—Etoposide—brain cancer	0.000163	0.000962	CcSEcCtD
Clomipramine—ABCB1—head—brain cancer	0.000163	0.00176	CbGeAlD
Clomipramine—Hypertension—Etoposide—brain cancer	0.000163	0.000958	CcSEcCtD
Clomipramine—Dizziness—Hydroxyurea—brain cancer	0.000163	0.000958	CcSEcCtD
Clomipramine—Gastrointestinal pain—Carmustine—brain cancer	0.000163	0.000958	CcSEcCtD
Clomipramine—Chest pain—Etoposide—brain cancer	0.00016	0.000945	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000159	0.000938	CcSEcCtD
Clomipramine—Discomfort—Etoposide—brain cancer	0.000158	0.000934	CcSEcCtD
Clomipramine—Feeling abnormal—Temozolomide—brain cancer	0.000158	0.000933	CcSEcCtD
Clomipramine—Body temperature increased—Carmustine—brain cancer	0.000157	0.000926	CcSEcCtD
Clomipramine—Abdominal pain—Carmustine—brain cancer	0.000157	0.000926	CcSEcCtD
Clomipramine—Gastrointestinal pain—Temozolomide—brain cancer	0.000157	0.000926	CcSEcCtD
Clomipramine—Vomiting—Hydroxyurea—brain cancer	0.000156	0.000921	CcSEcCtD
Clomipramine—Rash—Hydroxyurea—brain cancer	0.000155	0.000914	CcSEcCtD
Clomipramine—Confusional state—Etoposide—brain cancer	0.000155	0.000913	CcSEcCtD
Clomipramine—Dermatitis—Hydroxyurea—brain cancer	0.000155	0.000913	CcSEcCtD
Clomipramine—Headache—Hydroxyurea—brain cancer	0.000154	0.000908	CcSEcCtD
Clomipramine—Anaphylactic shock—Etoposide—brain cancer	0.000154	0.000906	CcSEcCtD
Clomipramine—Urticaria—Temozolomide—brain cancer	0.000153	0.000899	CcSEcCtD
Clomipramine—Body temperature increased—Temozolomide—brain cancer	0.000152	0.000895	CcSEcCtD
Clomipramine—Abdominal pain—Temozolomide—brain cancer	0.000152	0.000895	CcSEcCtD
Clomipramine—Thrombocytopenia—Etoposide—brain cancer	0.000151	0.000887	CcSEcCtD
Clomipramine—Tachycardia—Etoposide—brain cancer	0.00015	0.000884	CcSEcCtD
Clomipramine—Skin disorder—Etoposide—brain cancer	0.000149	0.00088	CcSEcCtD
Clomipramine—ABCB1—central nervous system—brain cancer	0.000149	0.00161	CbGeAlD
Clomipramine—Hyperhidrosis—Etoposide—brain cancer	0.000149	0.000876	CcSEcCtD
Clomipramine—Anorexia—Etoposide—brain cancer	0.000147	0.000863	CcSEcCtD
Clomipramine—Hypersensitivity—Carmustine—brain cancer	0.000147	0.000863	CcSEcCtD
Clomipramine—Nausea—Hydroxyurea—brain cancer	0.000146	0.000861	CcSEcCtD
Clomipramine—ABCB1—cerebellum—brain cancer	0.000145	0.00157	CbGeAlD
Clomipramine—Hypotension—Etoposide—brain cancer	0.000144	0.000846	CcSEcCtD
Clomipramine—Asthenia—Carmustine—brain cancer	0.000143	0.00084	CcSEcCtD
Clomipramine—Hypersensitivity—Temozolomide—brain cancer	0.000142	0.000834	CcSEcCtD
Clomipramine—Paraesthesia—Etoposide—brain cancer	0.000138	0.000813	CcSEcCtD
Clomipramine—Asthenia—Temozolomide—brain cancer	0.000138	0.000812	CcSEcCtD
Clomipramine—Dyspnoea—Etoposide—brain cancer	0.000137	0.000808	CcSEcCtD
Clomipramine—Somnolence—Etoposide—brain cancer	0.000137	0.000805	CcSEcCtD
Clomipramine—Diarrhoea—Carmustine—brain cancer	0.000136	0.000801	CcSEcCtD
Clomipramine—Pruritus—Temozolomide—brain cancer	0.000136	0.000801	CcSEcCtD
Clomipramine—Decreased appetite—Etoposide—brain cancer	0.000134	0.000787	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Etoposide—brain cancer	0.000133	0.000782	CcSEcCtD
Clomipramine—Fatigue—Etoposide—brain cancer	0.000133	0.000781	CcSEcCtD
Clomipramine—Dizziness—Carmustine—brain cancer	0.000132	0.000775	CcSEcCtD
Clomipramine—Constipation—Etoposide—brain cancer	0.000132	0.000775	CcSEcCtD
Clomipramine—Pain—Etoposide—brain cancer	0.000132	0.000775	CcSEcCtD
Clomipramine—Diarrhoea—Temozolomide—brain cancer	0.000131	0.000775	CcSEcCtD
Clomipramine—Dizziness—Temozolomide—brain cancer	0.000127	0.000749	CcSEcCtD
Clomipramine—Feeling abnormal—Etoposide—brain cancer	0.000127	0.000746	CcSEcCtD
Clomipramine—Vomiting—Carmustine—brain cancer	0.000126	0.000745	CcSEcCtD
Clomipramine—Gastrointestinal pain—Etoposide—brain cancer	0.000126	0.000741	CcSEcCtD
Clomipramine—Rash—Carmustine—brain cancer	0.000125	0.000739	CcSEcCtD
Clomipramine—Dermatitis—Carmustine—brain cancer	0.000125	0.000738	CcSEcCtD
Clomipramine—Headache—Carmustine—brain cancer	0.000125	0.000734	CcSEcCtD
Clomipramine—Vomiting—Temozolomide—brain cancer	0.000122	0.00072	CcSEcCtD
Clomipramine—Urticaria—Etoposide—brain cancer	0.000122	0.00072	CcSEcCtD
Clomipramine—Abdominal pain—Etoposide—brain cancer	0.000122	0.000716	CcSEcCtD
Clomipramine—Body temperature increased—Etoposide—brain cancer	0.000122	0.000716	CcSEcCtD
Clomipramine—Rash—Temozolomide—brain cancer	0.000121	0.000714	CcSEcCtD
Clomipramine—Dermatitis—Temozolomide—brain cancer	0.000121	0.000713	CcSEcCtD
Clomipramine—Headache—Temozolomide—brain cancer	0.00012	0.000709	CcSEcCtD
Clomipramine—Nausea—Carmustine—brain cancer	0.000118	0.000696	CcSEcCtD
Clomipramine—ABCB1—brain—brain cancer	0.000118	0.00128	CbGeAlD
Clomipramine—Nausea—Temozolomide—brain cancer	0.000114	0.000672	CcSEcCtD
Clomipramine—Hypersensitivity—Etoposide—brain cancer	0.000113	0.000667	CcSEcCtD
Clomipramine—Asthenia—Etoposide—brain cancer	0.00011	0.00065	CcSEcCtD
Clomipramine—Pruritus—Etoposide—brain cancer	0.000109	0.000641	CcSEcCtD
Clomipramine—Diarrhoea—Etoposide—brain cancer	0.000105	0.00062	CcSEcCtD
Clomipramine—Dizziness—Etoposide—brain cancer	0.000102	0.000599	CcSEcCtD
Clomipramine—Vomiting—Etoposide—brain cancer	9.78e-05	0.000576	CcSEcCtD
Clomipramine—Rash—Etoposide—brain cancer	9.7e-05	0.000571	CcSEcCtD
Clomipramine—Dermatitis—Etoposide—brain cancer	9.69e-05	0.000571	CcSEcCtD
Clomipramine—Headache—Etoposide—brain cancer	9.63e-05	0.000567	CcSEcCtD
Clomipramine—Nausea—Etoposide—brain cancer	9.13e-05	0.000538	CcSEcCtD
Clomipramine—ADRA2A—Signaling Pathways—STRADA—brain cancer	2.59e-05	0.000514	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—TRPC6—brain cancer	2.55e-05	0.000506	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—TRPC6—brain cancer	2.55e-05	0.000505	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—PTCH1—brain cancer	2.5e-05	0.000497	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—SMO—brain cancer	2.5e-05	0.000497	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—BSG—brain cancer	2.5e-05	0.000496	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—GLI1—brain cancer	2.49e-05	0.000493	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—PIK3CG—brain cancer	2.47e-05	0.00049	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—SHH—brain cancer	2.44e-05	0.000484	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—VAV1—brain cancer	2.42e-05	0.00048	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.42e-05	0.00048	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—NOTCH2—brain cancer	2.41e-05	0.000478	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—SHH—brain cancer	2.4e-05	0.000477	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—VAV1—brain cancer	2.39e-05	0.000474	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ABR—brain cancer	2.38e-05	0.000472	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SUFU—brain cancer	2.36e-05	0.000468	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TRPC6—brain cancer	2.35e-05	0.000467	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—PIK3CG—brain cancer	2.34e-05	0.000464	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CYP2C9—brain cancer	2.32e-05	0.00046	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—TRPC6—brain cancer	2.32e-05	0.00046	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—SMO—brain cancer	2.31e-05	0.000459	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PTCH1—brain cancer	2.31e-05	0.000459	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—VAV1—brain cancer	2.3e-05	0.000456	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—GLI2—brain cancer	2.3e-05	0.000456	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—SMO—brain cancer	2.28e-05	0.000452	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—PTCH1—brain cancer	2.28e-05	0.000452	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—GFAP—brain cancer	2.27e-05	0.000451	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	2.25e-05	0.000447	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2.25e-05	0.000446	CbGpPWpGaD
Clomipramine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—brain cancer	2.23e-05	0.000442	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—SHH—brain cancer	2.23e-05	0.000442	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—VAV1—brain cancer	2.2e-05	0.000436	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ABR—brain cancer	2.16e-05	0.000429	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—GLI1—brain cancer	2.16e-05	0.000428	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HEY1—brain cancer	2.16e-05	0.000428	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—IDH1—brain cancer	2.15e-05	0.000426	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TRPC6—brain cancer	2.15e-05	0.000426	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—DLL1—brain cancer	2.11e-05	0.000419	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—SMO—brain cancer	2.11e-05	0.000419	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PTCH1—brain cancer	2.11e-05	0.000419	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—VAV1—brain cancer	2.1e-05	0.000417	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—GLI2—brain cancer	2.09e-05	0.000414	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—PIK3CG—brain cancer	2.09e-05	0.000414	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CYP2C9—brain cancer	2.08e-05	0.000413	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	2.07e-05	0.000411	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SUFU—brain cancer	2.05e-05	0.000406	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CYP2C9—brain cancer	2.03e-05	0.000403	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.99e-05	0.000394	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—HES1—brain cancer	1.98e-05	0.000392	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—GFAP—brain cancer	1.97e-05	0.000392	CbGpPWpGaD
Clomipramine—ALB—Metabolism—BSG—brain cancer	1.97e-05	0.000391	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.97e-05	0.00039	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—GLI1—brain cancer	1.96e-05	0.00039	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—PIK3CG—brain cancer	1.92e-05	0.000381	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—IL2—brain cancer	1.92e-05	0.00038	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CYP2C9—brain cancer	1.91e-05	0.00038	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—VAV1—brain cancer	1.91e-05	0.000379	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—VAV1—brain cancer	1.91e-05	0.000379	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—PIK3CG—brain cancer	1.91e-05	0.000378	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—PIK3CG—brain cancer	1.9e-05	0.000376	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—PDGFRA—brain cancer	1.88e-05	0.000373	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HEY1—brain cancer	1.87e-05	0.000371	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SUFU—brain cancer	1.86e-05	0.000369	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—NOTCH2—brain cancer	1.85e-05	0.000367	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—DLL1—brain cancer	1.84e-05	0.000364	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—SPP1—brain cancer	1.83e-05	0.000363	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SHH—brain cancer	1.8e-05	0.000357	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—GFAP—brain cancer	1.8e-05	0.000356	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—BSG—brain cancer	1.77e-05	0.000351	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—VAV1—brain cancer	1.76e-05	0.00035	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	1.76e-05	0.000349	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—IL2—brain cancer	1.74e-05	0.000345	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—VAV1—brain cancer	1.74e-05	0.000345	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TRPC6—brain cancer	1.73e-05	0.000344	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.73e-05	0.000344	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—PIK3CG—brain cancer	1.73e-05	0.000343	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—BSG—brain cancer	1.73e-05	0.000343	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PTCH1—brain cancer	1.7e-05	0.000338	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SMO—brain cancer	1.7e-05	0.000338	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HEY1—brain cancer	1.7e-05	0.000338	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—ENO2—brain cancer	1.7e-05	0.000337	CbGpPWpGaD
Clomipramine—ALB—Metabolism—IDH1—brain cancer	1.7e-05	0.000336	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—NOTCH2—brain cancer	1.69e-05	0.000335	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—DLL1—brain cancer	1.67e-05	0.000331	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IRS2—brain cancer	1.65e-05	0.000328	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—BSG—brain cancer	1.63e-05	0.000323	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP2C9—brain cancer	1.62e-05	0.000322	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—VAV1—brain cancer	1.61e-05	0.000319	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.59e-05	0.000316	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SHH—brain cancer	1.56e-05	0.00031	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.56e-05	0.000309	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—PIK3CG—brain cancer	1.54e-05	0.000305	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—IDH1—brain cancer	1.52e-05	0.000302	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HES1—brain cancer	1.52e-05	0.000301	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—PIK3CG—brain cancer	1.52e-05	0.000301	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TRPC6—brain cancer	1.51e-05	0.000299	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—IDH1—brain cancer	1.49e-05	0.000295	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PTCH1—brain cancer	1.48e-05	0.000294	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SMO—brain cancer	1.48e-05	0.000294	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—IL2—brain cancer	1.47e-05	0.000291	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—APC—brain cancer	1.46e-05	0.00029	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—PIK3CG—brain cancer	1.46e-05	0.00029	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PDGFRA—brain cancer	1.44e-05	0.000286	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SHH—brain cancer	1.42e-05	0.000282	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—SPP1—brain cancer	1.4e-05	0.000278	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—IDH1—brain cancer	1.4e-05	0.000278	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—PIK3CG—brain cancer	1.4e-05	0.000277	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HES1—brain cancer	1.38e-05	0.000275	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.38e-05	0.000274	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—BSG—brain cancer	1.38e-05	0.000274	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TRPC6—brain cancer	1.37e-05	0.000272	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NOTCH2—brain cancer	1.36e-05	0.00027	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—IL2—brain cancer	1.35e-05	0.000268	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SMO—brain cancer	1.35e-05	0.000267	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PTCH1—brain cancer	1.35e-05	0.000267	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—IL2—brain cancer	1.34e-05	0.000266	CbGpPWpGaD
Clomipramine—ALB—Metabolism—ENO2—brain cancer	1.34e-05	0.000266	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—PIK3CG—brain cancer	1.33e-05	0.000265	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—IL2—brain cancer	1.33e-05	0.000265	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—EGFR—brain cancer	1.33e-05	0.000264	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PDGFRA—brain cancer	1.32e-05	0.000261	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.31e-05	0.00026	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—VAV1—brain cancer	1.3e-05	0.000258	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—SPP1—brain cancer	1.28e-05	0.000254	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IRS2—brain cancer	1.27e-05	0.000251	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP2C9—brain cancer	1.25e-05	0.000248	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.24e-05	0.000246	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—IL2—brain cancer	1.22e-05	0.000242	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—PIK3CG—brain cancer	1.21e-05	0.000241	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—PIK3CG—brain cancer	1.21e-05	0.00024	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ENO2—brain cancer	1.2e-05	0.000239	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—IDH1—brain cancer	1.19e-05	0.000235	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NOTCH2—brain cancer	1.18e-05	0.000235	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ENO2—brain cancer	1.17e-05	0.000233	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IRS2—brain cancer	1.16e-05	0.00023	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—VEGFA—brain cancer	1.15e-05	0.000228	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—RELA—brain cancer	1.14e-05	0.000226	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—ERBB2—brain cancer	1.13e-05	0.000225	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—VAV1—brain cancer	1.13e-05	0.000224	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PIK3CG—brain cancer	1.12e-05	0.000222	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—APC—brain cancer	1.12e-05	0.000222	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HES1—brain cancer	1.12e-05	0.000222	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ENO2—brain cancer	1.11e-05	0.00022	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	1.1e-05	0.000219	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—IL2—brain cancer	1.08e-05	0.000215	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	1.08e-05	0.000213	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—IL2—brain cancer	1.07e-05	0.000212	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—BSG—brain cancer	1.06e-05	0.000211	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PDGFRA—brain cancer	1.06e-05	0.000211	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SPP1—brain cancer	1.03e-05	0.000205	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IL2—brain cancer	1.03e-05	0.000204	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—VAV1—brain cancer	1.03e-05	0.000204	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—APC—brain cancer	1.02e-05	0.000203	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PIK3CG—brain cancer	1.02e-05	0.000203	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—EGFR—brain cancer	1.02e-05	0.000202	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CCND1—brain cancer	1e-05	0.000199	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CTNNB1—brain cancer	9.92e-06	0.000197	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL2—brain cancer	9.82e-06	0.000195	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HES1—brain cancer	9.7e-06	0.000192	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.66e-06	0.000192	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—IL2—brain cancer	9.39e-06	0.000186	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ENO2—brain cancer	9.37e-06	0.000186	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IRS2—brain cancer	9.34e-06	0.000185	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—EGFR—brain cancer	9.31e-06	0.000185	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PDGFRA—brain cancer	9.23e-06	0.000183	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—IDH1—brain cancer	9.15e-06	0.000182	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—VEGFA—brain cancer	9.07e-06	0.00018	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SPP1—brain cancer	8.96e-06	0.000178	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HES1—brain cancer	8.82e-06	0.000175	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—RELA—brain cancer	8.75e-06	0.000174	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—VEGFA—brain cancer	8.73e-06	0.000173	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—ERBB2—brain cancer	8.69e-06	0.000172	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—TP53—brain cancer	8.68e-06	0.000172	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—STAT3—brain cancer	8.65e-06	0.000171	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—IL2—brain cancer	8.55e-06	0.00017	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL2—brain cancer	8.53e-06	0.000169	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	8.4e-06	0.000167	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PIK3CG—brain cancer	8.25e-06	0.000164	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—APC—brain cancer	8.25e-06	0.000164	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SPP1—brain cancer	8.16e-06	0.000162	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IRS2—brain cancer	8.11e-06	0.000161	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MYC—brain cancer	8.03e-06	0.000159	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—RELA—brain cancer	7.99e-06	0.000158	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—ERBB2—brain cancer	7.94e-06	0.000157	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL2—brain cancer	7.88e-06	0.000156	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—EGFR—brain cancer	7.86e-06	0.000156	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PIK3CG—brain cancer	7.79e-06	0.000155	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL2—brain cancer	7.76e-06	0.000154	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CCND1—brain cancer	7.68e-06	0.000152	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CTNNB1—brain cancer	7.61e-06	0.000151	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—EGFR—brain cancer	7.51e-06	0.000149	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IRS2—brain cancer	7.38e-06	0.000146	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ENO2—brain cancer	7.24e-06	0.000144	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL2—brain cancer	7.19e-06	0.000143	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PIK3CG—brain cancer	7.16e-06	0.000142	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—APC—brain cancer	7.16e-06	0.000142	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CCND1—brain cancer	7.01e-06	0.000139	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CTNNB1—brain cancer	6.94e-06	0.000138	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—TP53—brain cancer	6.85e-06	0.000136	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—VEGFA—brain cancer	6.7e-06	0.000133	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—STAT3—brain cancer	6.63e-06	0.000132	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TP53—brain cancer	6.6e-06	0.000131	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—EGFR—brain cancer	6.52e-06	0.000129	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	6.51e-06	0.000129	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—APC—brain cancer	6.51e-06	0.000129	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—RELA—brain cancer	6.44e-06	0.000128	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—ERBB2—brain cancer	6.4e-06	0.000127	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MYC—brain cancer	6.16e-06	0.000122	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PIK3CG—brain cancer	6.15e-06	0.000122	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—VEGFA—brain cancer	6.11e-06	0.000121	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—STAT3—brain cancer	6.05e-06	0.00012	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—EGFR—brain cancer	6.03e-06	0.00012	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—EGFR—brain cancer	5.93e-06	0.000118	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL2—brain cancer	5.8e-06	0.000115	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCND1—brain cancer	5.66e-06	0.000112	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MYC—brain cancer	5.62e-06	0.000112	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CTNNB1—brain cancer	5.6e-06	0.000111	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—RELA—brain cancer	5.59e-06	0.000111	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ERBB2—brain cancer	5.56e-06	0.00011	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PIK3CG—brain cancer	5.52e-06	0.000109	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—EGFR—brain cancer	5.5e-06	0.000109	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PIK3CG—brain cancer	5.39e-06	0.000107	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—RELA—brain cancer	5.09e-06	0.000101	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PIK3CG—brain cancer	5.08e-06	0.000101	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TP53—brain cancer	5.06e-06	0.0001	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ERBB2—brain cancer	5.06e-06	0.0001	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL2—brain cancer	5.04e-06	0.0001	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—VEGFA—brain cancer	4.93e-06	9.78e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCND1—brain cancer	4.91e-06	9.74e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—STAT3—brain cancer	4.88e-06	9.69e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CTNNB1—brain cancer	4.86e-06	9.65e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TP53—brain cancer	4.62e-06	9.16e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL2—brain cancer	4.58e-06	9.09e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MYC—brain cancer	4.54e-06	9e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCND1—brain cancer	4.47e-06	8.86e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—EGFR—brain cancer	4.44e-06	8.8e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	4.43e-06	8.78e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PIK3CG—brain cancer	4.3e-06	8.53e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—VEGFA—brain cancer	4.28e-06	8.49e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—STAT3—brain cancer	4.24e-06	8.41e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MYC—brain cancer	3.94e-06	7.82e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—VEGFA—brain cancer	3.9e-06	7.73e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—STAT3—brain cancer	3.86e-06	7.65e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—EGFR—brain cancer	3.85e-06	7.64e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TP53—brain cancer	3.73e-06	7.39e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MYC—brain cancer	3.58e-06	7.11e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—EGFR—brain cancer	3.51e-06	6.95e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PIK3CG—brain cancer	3.32e-06	6.58e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TP53—brain cancer	3.24e-06	6.42e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TP53—brain cancer	2.94e-06	5.84e-05	CbGpPWpGaD
